Primary Site >> Colorectal Cancer
Gene >> IRAK1
| 1. | |||||||||||
| Journal: | Int J Oncol. 2004 May;24(5):1279-88. | ||||||||||
| Title: | Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. | ||||||||||
| Author: | de Angelis, Paula M|Fjell, Bjorg|Kravik, Katherine L|Haug, Terje|Tunheim, Siv H|Reichelt, Wenche|Beigi, Marzieh|Clausen, Ole Petter|Galteland, Eivind|Stokke, Trond | ||||||||||
| PMID: | 15067352 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Res. 2011 May 15;71(10):3635-48. | ||||||||||
| Title: | The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models. | ||||||||||
| Author: | LaBonte, Melissa J|Wilson, Peter M|Fazzone, Will|Russell, Jared|Louie, Stan G|El-Khoueiry, Anthony|Lenz, Heinz-Josef|Ladner, Robert D | ||||||||||
| PMID: | 21464044 | ||||||||||
| 3. | |||||||||||
| Journal: | EBioMedicine. 2017 Feb;15:36-47. | ||||||||||
| Title: | Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M. | ||||||||||
| Author: | Rothschild, Daniel E|Zhang, Yao|Diao, Na|Lee, Christina K|Chen, Keqiang|Caswell, Clayton C|Slade, Daniel J|Helm, Richard F|LeRoith, Tanya|Li, Liwu|Allen, Irving C | ||||||||||
| PMID: | 27939424 | ||||||||||
| 4. | |||||||||||
| Journal: | PLoS Genet. 2017 Mar 15;13(3):e1006672. | ||||||||||
| Title: | hnRNP I regulates neonatal immune adaptation and prevents colitis and colorectal cancer. | ||||||||||
| Author: | Jin, Zhigang|Liang, Feng|Yang, Jing|Mei, Wenyan | ||||||||||
| PMID: | 28296893 | ||||||||||